Jan 6 2012
China Kanghui Holdings (NYSE: KH) ("Kanghui" or the "Company"), a leading domestic developer, manufacturer and marketer of orthopedic implants in China, today announced that the Company's wholly-owned subsidiary, TGM Medical, Inc. ("TGM"), has received approvals from the Food and Drug Administration of the United States (the "FDA") for its Helicon™ Hip System ("HHS"), Milestone Knee System ("MKS") and related surgical instruments.
Mr. Libo Yang, Chief Executive Officer of the Company, stated, "We are very pleased that our recent acquisitions not only have laid a strong foundation for our future growth but also provide us with strong momentum for 2012. With successful FDA approvals for TGM's HHS and MKS, we are well-positioned to launch these products this year to kick start our reconstructive joint segment. We have a good start in 2012 and will continue to implement our business opportunities and growth strategies."